Internal Medicine, Gastroenterology · Ogden, UT
NPI
1649266776
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6028 S Ridgeline Dr, Suite 201
Ogden, UT, 84405
Phone (801) 475-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
1,962 services
Medicare patients, 2024
673
Average age 73
Drug cost, 2024
$326K
1,883 prescriptions
Company payments, 2025
$907
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Poole was code 43239 (upper gi endoscopy), 279 times for 267 patients. In total Jeffrey S Poole billed 1,962 services in 62 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 279 | 267 | $47.09 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 252 | 250 | $102.46 | $26K |
| 43249 Upper GI Endoscopy | Facility | 144 | 136 | $96.15 | $14K |
| 45385 Colonoscopy - Lesion Removal | Facility | 136 | 136 | $186.83 | $25K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 76 | 76 | $171.34 | $13K |
| 99214 Office E&M - Established | Office | 59 | 52 | $84.11 | $4,962 |
| 99222 Hospital E&M - Initial | Facility | 39 | 39 | $98.09 | $3,826 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 31 | 31 | $166.90 | $5,174 |
| 99213 Office E&M - Established | Office | 29 | 26 | $61.40 | $1,780 |
| 36415 Venipuncture Blood Collection | Office | 22 | 18 | $8.65 | $190 |
| 45378 Lower GI Endoscopy - Other | Facility | 19 | 18 | $121.76 | $2,313 |
| 85025 Blood Count | Office | 16 | 13 | $7.61 | $122 |
| 99204 Office E&M - New | Office | 16 | 16 | $113.81 | $1,821 |
| 80053 Clinical Chemistry | Office | 16 | 13 | $10.35 | $166 |
| 43245 Upper GI Endoscopy | Facility | 12 | 11 | $115.24 | $1,383 |
By year: 2022 $154K for 3,489 services; 2023 $132K for 2,591 services; 2024 $129K for 1,962 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 18 | $8.65 | $190 |
| 80053 Clinical Chemistry | 16 | 13 | $10.35 | $166 |
| 85025 Blood Count | 16 | 13 | $7.61 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Poole prescribed most often to Medicare patients was Pantoprazole Sodium, with 532 prescriptions and refills. In total Jeffrey S Poole wrote 1,883 Medicare prescriptions that cost $326K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 532 | 1,395 | 231 | $5,950 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 305 | 326 | 298 | $53K |
| Sucralfate Generic | 201 | 231 | 121 | $6,439 |
| Omeprazole Generic | 170 | 447 | 65 | $3,735 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 115 | 115 | 111 | $1,912 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 94 | 94 | 93 | $15K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 74 | 74 | 72 | $5,133 |
| Movantik Naloxegol Oxalate | 47 | 51 | 13 | $21K |
| Metronidazole Generic | 36 | 36 | 35 | $394 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 32 | 32 | 32 | $3,997 |
| Ursodiol Generic | 18 | 31 | Under 11 | $2,002 |
| Linzess Linaclotide | 18 | 26 | Under 11 | $14K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 18 | 18 | 18 | $285 |
| Famotidine Generic | 15 | 33 | Under 11 | $125 |
| Mesalamine Generic | 12 | 32 | Under 11 | $9,962 |
Brand drugs: 634 claims; generic drugs: 1,249 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Poole $907 ($907 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $295.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $183 |
| Pfizer Inc. PFE | 17 | $170 |
| Janssen Biotech, Inc. JNJ | 4 | $72.8 |
| Ardelyx, Inc. ARDX | 3 | $49.34 |
| QOL Medical, LLC | 1 | $32.17 |
| CapsoVision, Inc. CV | 1 | $25.07 |
| Biocon Biologics Inc | 1 | $23.9 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $20.24 |
| Genzyme Corporation SNY | 1 | $17.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.